메뉴 건너뛰기




Volumn 10, Issue 4, 2011, Pages 434-440

Evolution of hepatitis b virus during long-term therapy in patients with chronic hepatitis B

Author keywords

ADV; ETV; LAM; Mutations; Resistance

Indexed keywords

ADEFOVIR; DNA POLYMERASE; ENTECAVIR; LAMIVUDINE; RNA DIRECTED DNA POLYMERASE; VIRUS DNA;

EID: 80052724383     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31509-1     Document Type: Article
Times cited : (7)

References (35)
  • 1
    • 33644858331 scopus 로고    scopus 로고
    • Risk evaluation of viral load elevation and associated liver disease/cancer-in HBV (the REVEAL-HBV) study group. Predicting cirrhosis risk based on the level of circulating hepatitis B virus load
    • Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ. Risk evaluation of viral load elevation and associated liver disease/cancer-in HBV (the REVEAL-HBV) study group. Predicting cirrhosis risk based on the level of circulating hepatitis B virus load. Gastroenterology 2006; 130: 678-86.
    • (2006) Gastroenterology , vol.130 , pp. 678-686
    • Iloeje, U.H.1    Yang, H.I.2    Su, J.3    Jen, C.L.4    You, S.L.5    Chen, C.J.6
  • 2
    • 39849100002 scopus 로고    scopus 로고
    • Chronic HBV-related liver disease
    • Rizzetto M, Ciancio A. Chronic HBV-related liver disease. Mol Aspects Med 2008; 29: 72-84.
    • (2008) Mol Aspects Med , vol.29 , pp. 72-84
    • Rizzetto, M.1    Ciancio, A.2
  • 4
    • 0036892435 scopus 로고    scopus 로고
    • Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection
    • Lai CL, Lao J, Van Vlierberghe H, Anderson FH, Thomas N, Dehertogh D. Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection. Gastroenterology 2002; 123: 1831-8.
    • (2002) Gastroenterology , vol.123 , pp. 1831-1838
    • Lai, C.L.1    Lao, J.2    van Vlierberghe, H.3    Anderson, F.H.4    Thomas, N.5    Dehertogh, D.6
  • 5
    • 62149121677 scopus 로고    scopus 로고
    • Evolution of hepatitis B virus polymerase mutations in a patient with HBeAg-positive chronic hepatitis B virus treated with sequential monotherapy and add-on nucleoside/nucleotide analogues
    • Wang F, Wang H, Shen H, Meng C, Weng X, Zhang W. Evolution of hepatitis B virus polymerase mutations in a patient with HBeAg-positive chronic hepatitis B virus treated with sequential monotherapy and add-on nucleoside/nucleotide analogues. Clin Ther 2009; 31: 360-6.
    • (2009) Clin Ther , vol.31 , pp. 360-366
    • Wang, F.1    Wang, H.2    Shen, H.3    Meng, C.4    Weng, X.5    Zhang, W.6
  • 6
    • 1542407372 scopus 로고    scopus 로고
    • Therapeutic advances in chronic hepatitis B
    • Lai CL. Therapeutic advances in chronic hepatitis B. J Gastroenterol Hepatol 2004; 19: S5-S9.
    • (2004) J Gastroenterol Hepatol , vol.19
    • Lai, C.L.1
  • 7
    • 38749126832 scopus 로고    scopus 로고
    • Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: Recommendations for a standardized approach
    • Pawlotsky JM, Dusheiko G, Hatzakis A, Lau D, Lau G, Liang TJ, Locarnini S, et al. Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach. Gastroenterology 2008; 134: 405-15.
    • (2008) Gastroenterology , vol.134 , pp. 405-415
    • Pawlotsky, J.M.1    Dusheiko, G.2    Hatzakis, A.3    Lau, D.4    Lau, G.5    Liang, T.J.6    Locarnini, S.7
  • 8
    • 67349287021 scopus 로고    scopus 로고
    • A sensitive direct sequencing assay based on nested PCR for the detection of HBV polymerase and surface glycoprotein mutations
    • Vincenti D, Solmone M, Garbuglia AR, Iacomi F, Capobianchi MR. A sensitive direct sequencing assay based on nested PCR for the detection of HBV polymerase and surface glycoprotein mutations. J Virol Methods 2009; 159: 53-7.
    • (2009) J Virol Methods , vol.159 , pp. 53-57
    • Vincenti, D.1    Solmone, M.2    Garbuglia, A.R.3    Iacomi, F.4    Capobianchi, M.R.5
  • 10
    • 39149121860 scopus 로고    scopus 로고
    • Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: Characterization of genotype G in Brasil
    • Bottecchia M, Souto FJ, O KM, Amendola M, Brandão CE, Niel C, Gomes SA. Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: characterization of genotype G in Brasil. BMC Microbiol 2008; 22: 8-11.
    • (2008) BMC Microbiol , vol.22 , pp. 8-11
    • Bottecchia, M.1    Souto, F.J.2    Km, O.3    Amendola, M.4    Brandão, C.E.5    Niel, C.6    Gomes, S.A.7
  • 11
    • 21344460718 scopus 로고    scopus 로고
    • Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine
    • Papatheodoridis GV, Dimou E, Dimakopoulos K, Manolakopoulos S, Rapti I, Kitis G, Tzourmakliotis D, et al. Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine. Hepatology 2005; 42: 121-9.
    • (2005) Hepatology , vol.42 , pp. 121-129
    • Papatheodoridis, G.V.1    Dimou, E.2    Dimakopoulos, K.3    Manolakopoulos, S.4    Rapti, I.5    Kitis, G.6    Tzourmakliotis, D.7
  • 12
    • 30344458192 scopus 로고    scopus 로고
    • Cellular and virological mechanisms of HBV drug resistance
    • Locarnini S, Mason WS. Cellular and virological mechanisms of HBV drug resistance. J Hepatol 2006; 44: 422-31.
    • (2006) J Hepatol , vol.44 , pp. 422-431
    • Locarnini, S.1    Mason, W.S.2
  • 13
    • 32444438958 scopus 로고    scopus 로고
    • Adefovir rapidly suppresses hepatitis B in HBe-Ag-negative patients developing genotypic resistance to lamivudine
    • Lampertico P, Viganó M, Manenti E, Iavarone M, Lunghi G, Colombo M. Adefovir rapidly suppresses hepatitis B in HBe-Ag-negative patients developing genotypic resistance to lamivudine. Hepatology 2005; 42: 1414-9.
    • (2005) Hepatology , vol.42 , pp. 1414-1419
    • Lampertico, P.1    Viganó, M.2    Manenti, E.3    Iavarone, M.4    Lunghi, G.5    Colombo, M.6
  • 14
    • 33745152347 scopus 로고    scopus 로고
    • Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2)
    • Osiowy C, Villeneuve JP, Heathcote EJ, Giles E, Borlang J. Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2). J Clin Microbiol 2006; 44: 1994-7.
    • (2006) J Clin Microbiol , vol.44 , pp. 1994-1997
    • Osiowy, C.1    Villeneuve, J.P.2    Heathcote, E.J.3    Giles, E.4    Borlang, J.5
  • 15
    • 34547425435 scopus 로고    scopus 로고
    • Antiviral drug-resistant HBV: Standardization of nomenclature and assays and recommendations for management
    • Lok AS, Zoulim F, Locarnini S, Bartholomeusz A, Ghany MG, Pawlotsky JM, Liaw YF, et al. Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 2007; 46: 254-65.
    • (2007) Hepatology , vol.46 , pp. 254-265
    • Lok, A.S.1    Zoulim, F.2    Locarnini, S.3    Bartholomeusz, A.4    Ghany, M.G.5    Pawlotsky, J.M.6    Liaw, Y.F.7
  • 16
    • 75449117145 scopus 로고    scopus 로고
    • Molecular evolutionary analysis and mutational pattern of full-length genomes of hepatitis B virus isolated from Belgian patients with different clinical manifestations
    • Pourkarim MR, Amini-Bavil-Olyaee S, Verbeeck J, Lemey P, Zeller M, Rahman M, Maes P, et al. Molecular evolutionary analysis and mutational pattern of full-length genomes of hepatitis B virus isolated from Belgian patients with different clinical manifestations. J Med Virol 2010; 82: 379-89.
    • (2010) J Med Virol , vol.82 , pp. 379-389
    • Pourkarim, M.R.1    Amini-Bavil-Olyaee, S.2    Verbeeck, J.3    Lemey, P.4    Zeller, M.5    Rahman, M.6    Maes, P.7
  • 17
    • 33745594824 scopus 로고    scopus 로고
    • Hepatitis B virus genetic diversity
    • Echevarría JM, Avellón A. Hepatitis B virus genetic diversity. J Med Virol 2006; 78: 36-42.
    • (2006) J Med Virol , vol.78 , pp. 36-42
    • Echevarría, J.M.1    Avellón, A.2
  • 18
    • 0035942013 scopus 로고    scopus 로고
    • 20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw
    • Zöllner B, Petersen J, Schröter M, Laufs R, Schoder V, Feucht HH. 20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw. Lancet 2001; 24: 934-5.
    • (2001) Lancet , vol.24 , pp. 934-935
    • Zöllner, B.1    Petersen, J.2    Schröter, M.3    Laufs, R.4    Schoder, V.5    Feucht, H.H.6
  • 19
    • 67650120123 scopus 로고    scopus 로고
    • Current prophylactic strategies against hepatitis B virus recurrence after liver transplantation
    • Jiang L, Jiang LS, Cheng NS, Yan LN. Current prophylactic strategies against hepatitis B virus recurrence after liver transplantation. World J Gastroenterol 2009; 15: 2489-99.
    • (2009) World J Gastroenterol , vol.15 , pp. 2489-2499
    • Jiang, L.1    Jiang, L.S.2    Cheng, N.S.3    Yan, L.N.4
  • 20
    • 33748317138 scopus 로고    scopus 로고
    • Evolution of multi-drug resistant hepatitis B virus during sequential therapy
    • Yim HJ, Hussain M, Liu Y, Wong SN, Fung SK, Lok AS. Evolution of multi-drug resistant hepatitis B virus during sequential therapy. Hepatology 2006; 44: 703-12.
    • (2006) Hepatology , vol.44 , pp. 703-712
    • Yim, H.J.1    Hussain, M.2    Liu, Y.3    Wong, S.N.4    Fung, S.K.5    Lok, A.S.6
  • 22
    • 43049168909 scopus 로고    scopus 로고
    • Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: Twoyear follow-up
    • Yatsuji H, Suzuki F, Sezaki H, Akuta N, Suzuki Y, Kawamura Y, Hosaka T, et al. Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: twoyear follow-up. J Hepatol 2008; 48: 923-31.
    • (2008) J Hepatol , vol.48 , pp. 923-931
    • Yatsuji, H.1    Suzuki, F.2    Sezaki, H.3    Akuta, N.4    Suzuki, Y.5    Kawamura, Y.6    Hosaka, T.7
  • 23
    • 73449121925 scopus 로고    scopus 로고
    • Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues
    • van Bömmel F, de Man RA, Wedemeyer H, Deterding K, Petersen J, Buggisch P, Erhardt A, et al. Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues. Hepatology 2010; 51: 73-80.
    • (2010) Hepatology , vol.51 , pp. 73-80
    • van Bömmel, F.1    de Man, R.A.2    Wedemeyer, H.3    Deterding, K.4    Petersen, J.5    Buggisch, P.6    Erhardt, A.7
  • 24
    • 79955605804 scopus 로고    scopus 로고
    • Initial virological response and viral mutation with adefovir dipivoxil added to ongoing lamivudine therapy in lamivudine-resistant chronic hepatitis B
    • Wu S, Fukai K, Imazeki F, Arai M, Kanda T, Yonemitsu Y, Yokosuka O. Initial virological response and viral mutation with adefovir dipivoxil added to ongoing lamivudine therapy in lamivudine-resistant chronic hepatitis B. Dig Dis Sci 2011; 56: 1207-14.
    • (2011) Dig Dis Sci , vol.56 , pp. 1207-1214
    • Wu, S.1    Fukai, K.2    Imazeki, F.3    Arai, M.4    Kanda, T.5    Yonemitsu, Y.6    Yokosuka, O.7
  • 25
    • 37249029182 scopus 로고    scopus 로고
    • Evolution of primary and compensatory lamivudine resistance mutations in chronic hepatitis B virus-infected patients during long-term lamivudine treatment, assessed by a line probe assay
    • Libbrecht E, Doutreloigne J, Van De Velde H, Yuen MF, Lai CL, Shapiro F, Sablon E. Evolution of primary and compensatory lamivudine resistance mutations in chronic hepatitis B virus-infected patients during long-term lamivudine treatment, assessed by a line probe assay. J Clin Microbiol 2007; 45: 3935-41.
    • (2007) J Clin Microbiol , vol.45 , pp. 3935-3941
    • Libbrecht, E.1    Doutreloigne, J.2    van de Velde, H.3    Yuen, M.F.4    Lai, C.L.5    Shapiro, F.6    Sablon, E.7
  • 26
    • 60049099815 scopus 로고    scopus 로고
    • Association of lamivudine-resistant mutational patterns with the antiviral effect of adefovir in patients with chronic hepatitis B
    • Cha CK, Kwon HC, Cheong JY, Cho SW, Hong SP, Kim SO, Yoo WD. Association of lamivudine-resistant mutational patterns with the antiviral effect of adefovir in patients with chronic hepatitis B. J Med Virol 2009; 81: 417-24.
    • (2009) J Med Virol , vol.81 , pp. 417-424
    • Cha, C.K.1    Kwon, H.C.2    Cheong, J.Y.3    Cho, S.W.4    Hong, S.P.5    Kim, S.O.6    Yoo, W.D.7
  • 27
    • 34247222010 scopus 로고    scopus 로고
    • Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B
    • Ghany M, Liang TJ. Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B. Gastroenterology 2007; 132: 1574-85.
    • (2007) Gastroenterology , vol.132 , pp. 1574-1585
    • Ghany, M.1    Liang, T.J.2
  • 28
    • 33646369149 scopus 로고    scopus 로고
    • Antiviral drug resistance: Clinical consequences and molecular aspects
    • Bartholomeusz A, Locarnini SA. Antiviral drug resistance: clinical consequences and molecular aspects. Semin Liver Dis 2006; 26: 162-70.
    • (2006) Semin Liver Dis , vol.26 , pp. 162-170
    • Bartholomeusz, A.1    Locarnini, S.A.2
  • 29
    • 69949156498 scopus 로고    scopus 로고
    • Prevalence, viral replication efficiency and antiviral drug susceptibility of rtQ215 polymerase mutations within the hepatitis B virus genome
    • Amini-Bavil-Olyaee S, Herbers U, Mohebbi SR, Sabahi F, Zali MR, Luedde T, Trautwein C, et al. Prevalence, viral replication efficiency and antiviral drug susceptibility of rtQ215 polymerase mutations within the hepatitis B virus genome. J Hepatol 2009; 51: 647-54.
    • (2009) J Hepatol , vol.51 , pp. 647-654
    • Amini-Bavil-Olyaee, S.1    Herbers, U.2    Mohebbi, S.R.3    Sabahi, F.4    Zali, M.R.5    Luedde, T.6    Trautwein, C.7
  • 30
    • 59349104768 scopus 로고    scopus 로고
    • The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes
    • Svicher V, Gori C, Trignetti M, Visca M, Micheli V, Bernassola M, Salpini R, et al. The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes. J Hepatol 2009; 50: 461-70.
    • (2009) J Hepatol , vol.50 , pp. 461-470
    • Svicher, V.1    Gori, C.2    Trignetti, M.3    Visca, M.4    Micheli, V.5    Bernassola, M.6    Salpini, R.7
  • 32
    • 33847683844 scopus 로고    scopus 로고
    • Two-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions present
    • Tenney DJ, Rose RE, Baldick CJ, Levine SM, Pokornowski KA, Walsh AW, Fang J, et al. Two-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions present. Antimicrob Agents Chemother 2007; 51: 902-11.
    • (2007) Antimicrob Agents Chemother , vol.51 , pp. 902-911
    • Tenney, D.J.1    Rose, R.E.2    Baldick, C.J.3    Levine, S.M.4    Pokornowski, K.A.5    Walsh, A.W.6    Fang, J.7
  • 33
    • 43949100366 scopus 로고    scopus 로고
    • Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance
    • Baldick CJ, Tenney DJ, Mazzucco CE, Eggers BJ, Rose RE, Pokornowski KA, Yu CF, et al. Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance. Hepatology 2008; 47: 1473-82.
    • (2008) Hepatology , vol.47 , pp. 1473-1482
    • Baldick, C.J.1    Tenney, D.J.2    Mazzucco, C.E.3    Eggers, B.J.4    Rose, R.E.5    Pokornowski, K.A.6    Yu, C.F.7
  • 34
    • 66149115173 scopus 로고    scopus 로고
    • Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside- naïve patients is rare through 5 years of therapy
    • Tenney DJ, Rose RE, Baldick CJ, Pokornowski KA, Eggers BJ, Fang J, Wichroski MJ, et al. Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside- naïve patients is rare through 5 years of therapy. Hepatology 2009; 49: 1503-14.
    • (2009) Hepatology , vol.49 , pp. 1503-1514
    • Tenney, D.J.1    Rose, R.E.2    Baldick, C.J.3    Pokornowski, K.A.4    Eggers, B.J.5    Fang, J.6    Wichroski, M.J.7
  • 35
    • 70350050776 scopus 로고    scopus 로고
    • Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone
    • Shim JH, Suh DJ, Kim KM, Lim YS, Lee HC, Chung YH, Lee YS. Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone. Hepatology 2009; 50: 1064-71.
    • (2009) Hepatology , vol.50 , pp. 1064-1071
    • Shim, J.H.1    Suh, D.J.2    Kim, K.M.3    Lim, Y.S.4    Lee, H.C.5    Chung, Y.H.6    Lee, Y.S.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.